Advice
Discontinuation of docetaxel (Taxotere)
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.
Medicine details
- Medicine name:
- docetaxel (Taxotere)
- SMC ID:
- 659/10
- Indication:
- for the treatment of patients with operable node-negative breast cancer.
- Pharmaceutical company
- Sanofi-Aventis
- BNF chapter
- Malignant disease and immunosuppression
- Submission type
- Non submission
- Status
- Withdrawn
- Date advice published
- 08 November 2010
Additional notes
The manufacturer, Sanofi, have confirmed that docetaxel (Taxotere) has been discontinued.